Stay updated on Pembrolizumab Effects in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Effects in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Effects in Solid Tumors Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The changes are limited to the site's footer: a new Revision: v3.4.2 tag and updated/removed generic operating-status notices. There is no impact on the study details, eligibility criteria, or data presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T01:59:29.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding has been added and the page revision updated to v3.4.1 (replacing v3.4.0).
    Difference
    0.5%
    Check dated 2026-02-03T23:25:19.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Show glossary has been added, and a new 'Last Update Submitted that Met QC Criteria' field is displayed. The old 'Last Update Submitted that met QC Criteria' label, casing of 'No FEAR Act data', and the page revision have been updated to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-27T23:56:38.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Footer shows a minor version update: Revision v3.3.4 added and v3.3.3 removed; no changes to study details, eligibility, or endpoints are apparent.
    Difference
    0.1%
    Check dated 2026-01-14T01:21:23.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Added Locations: Ontario (Toronto, Princess Margaret Cancer Centre). Removed Ontario Locations header and HHS Vulnerability Disclosure; updated page revision to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T10:11:02.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:58:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Effects in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Effects in Solid Tumors Clinical Trial page.